Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 466582015 | Aclarubicin 20mg injection (pdr for recon) | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 719217014 | Aclarubicin 20mg injection (pdr for recon) (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1191219015 | Aclarubicin 20mg injection (pdr for recon) (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1763459012 | Aclarubicin 20mg powder for injection solution vial (product) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 1775865016 | Aclarubicin 20mg powder for injection solution vial | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3769571013 | Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3769572018 | Aclarubicin 20 mg powder for solution for injection vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product containing aclarubicin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has active ingredient | Aclarubicin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Aclarubicin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has basis of strength substance | Aclarubicin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Vial | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit | Vial | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product containing only aclarubicin in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Aclarubicin 20mg injection (pdr for recon) - product | Is a | False | Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR